DEXCOM INC — Director's Dealing 2020

Jul 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-07-23

Reporting Person: Pacelli Steven Robert (EVP Strategy and Corporate Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-23	Common Stock	S	200	$421.615	Disposed	75739	Direct
2020-07-23	Common Stock	S	100	$424.5	Disposed	75639	Direct
2020-07-23	Common Stock	S	437	$427.2115	Disposed	75202	Direct
2020-07-23	Common Stock	S	211	$428.097	Disposed	74991	Direct
2020-07-23	Common Stock	S	583	$429.5379	Disposed	74408	Direct

Footnotes

F1: On June 11, 2019, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 31,636 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

F3: This transaction was executed in multiple trades at prices ranging from $426.49 to $427.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F4: This transaction was executed in multiple trades at prices ranging from $427.83 to $428.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $428.83 to $429.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.